An Audacy listing page gathering coverage on BPC-157 and peptides alongside Kennedy and Trump, with no story details given.
Recap by typeshit. Full story at Audacy.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Two people familiar with the policy say pharmacies would get temporary cover to make popular peptides, even though FDA staff scientists found them understudied.
Dr Leana Wen, Robert Gebelhoff and Dominic Pino talk through the range of side effects that can come with GLP-1 drugs such as Ozempic.
Loading…